Mutual antagonism between the ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome

Cell Host and Microbe

Volumn 14, Issue 1, 2013, Pages 74-84

  Luthra, Priya ^a   Ramanan, Parameshwaran ^b,c   Mire, Chad E ^d   Weisend, Carla ^e   Tsuda, Yoshimi ^e   Yen, Benjamin ^a   Liu, Gai ^b   Leung, Daisy W ^b   Geisbert, Thomas W ^d   Ebihara, Hideki ^e   Amarasinghe, Gaya K ^b   Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS RNA; VP35 PROTEIN;

ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; VIRUS CELL INTERACTION; VIRUS MUTANT; WILD TYPE;

EID: 84880445500     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.06.010     Document Type: Article

References (47)

1. S. Bale, J.P. Julien, Z.A. Bornholdt, C.R. Kimberlin, P. Halfmann, M.A. Zandonatti, J. Kunert, G.J. Kroon, Y. Kawaoka, and I.J. MacRae Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism PLoS Pathog. 8 2012 e1002916 10.1371/journal.ppat.1002916
2. C.F. Basler, and G.K. Amarasinghe Evasion of interferon responses by Ebola and Marburg viruses J. Interferon Cytokine Res. 29 2009 511 520
3. C.F. Basler, X. Wang, E. Mühlberger, V. Volchkov, J. Paragas, H.D. Klenk, A. García-Sastre, and P. Palese The Ebola virus VP35 protein functions as a type I IFN antagonist Proc. Natl. Acad. Sci. USA 97 2000 12289 12294
4. C.F. Basler, A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Mühlberger, M. Bray, H.D. Klenk, P. Palese, and A. García-Sastre The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 J. Virol. 77 2003 7945 7956
5. S. Becker, C. Rinne, U. Hofsäss, H.D. Klenk, and E. Mühlberger Interactions of Marburg virus nucleocapsid proteins Virology 249 1998 406 417
6. W.B. Cardenas, Y.M. Loo, M. Gale Jr., A.L. Hartman, C.R. Kimberlin, L. Martínez-Sobrido, E.O. Saphire, and C.F. Basler Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling J. Virol. 80 2006 5168 5178
7. T.H. Chang, T. Kubota, M. Matsuoka, S. Jones, S.B. Bradfute, M. Bray, and K. Ozato Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery PLoS Pathog. 5 2009 e1000493 10.1371/journal.ppat.1000493
8. T.P. Chendrimada, R.I. Gregory, E. Kumaraswamy, J. Norman, N. Cooch, K. Nishikura, and R. Shiekhattar TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing Nature 436 2005 740 744
9. H. Ebihara, A. Takada, D. Kobasa, S. Jones, G. Neumann, S. Theriault, M. Bray, H. Feldmann, and Y. Kawaoka Molecular determinants of Ebola virus virulence in mice PLoS Pathog. 2 2006 e73 10.1371/journal.ppat.0020073
10. G. Fabozzi, C.S. Nabel, M.A. Dolan, and N.J. Sullivan Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway J. Virol. 85 2011 2512 2523
11. H. Feldmann, S. Jones, H.D. Klenk, and H.J. Schnittler Ebola virus: from discovery to vaccine Nat. Rev. Immunol. 3 2003 677 685
12. Z. Feng, M. Cerveny, Z. Yan, and B. He The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR J. Virol. 81 2007 182 192
13. A.D. Haase, L. Jaskiewicz, H. Zhang, S. Lainé, R. Sack, A. Gatignol, and W. Filipowicz TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing EMBO Rep. 6 2005 961 967
14. J. Haasnoot, W. de Vries, E.J. Geutjes, M. Prins, P. de Haan, and B. Berkhout The Ebola virus VP35 protein is a suppressor of RNA silencing PLoS Pathog. 3 2007 e86 10.1371/journal.ppat.0030086
15. A.L. Hartman, J.E. Dover, J.S. Towner, and S.T. Nichol Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication J. Virol. 80 2006 6430 6440
16. A.L. Hartman, B.H. Bird, J.S. Towner, Z.A. Antoniadou, S.R. Zaki, and S.T. Nichol Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus J. Virol. 82 2008 2699 2704
17. A.L. Hartman, L. Ling, S.T. Nichol, and M.L. Hibberd Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein J. Virol. 82 2008 5348 5358
18. T. Ito, M. Yang, and W.S. May RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling J. Biol. Chem. 274 1999 15427 15432
19. T. Iwamura, M. Yoneyama, N. Koizumi, Y. Okabe, H. Namiki, C.E. Samuel, and T. Fujita PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus Biochem. Biophys. Res. Commun. 282 2001 515 523
20. C.R. Kimberlin, Z.A. Bornholdt, S. Li, V.L. Woods Jr., I.J. MacRae, and E.O. Saphire Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression Proc. Natl. Acad. Sci. USA 107 2010 314 319
21. K.H. Kok, M.H. Ng, Y.P. Ching, and D.Y. Jin Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA J. Biol. Chem. 282 2007 17649 17657
22. K.H. Kok, P.Y. Lui, M.H. Ng, K.L. Siu, S.W. Au, and D.Y. Jin The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response Cell Host Microbe 9 2011 299 309
23. Y. Lee, I. Hur, S.Y. Park, Y.K. Kim, M.R. Suh, and V.N. Kim The role of PACT in the RNA silencing pathway EMBO J. 25 2006 522 532
24. H.Y. Lee, K. Zhou, A.M. Smith, C.L. Noland, and J.A. Doudna Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing Nucleic Acids Res. 2013 10.1093/nar/gkt361
25. D.W. Leung, N.D. Ginder, D.B. Fulton, J. Nix, C.F. Basler, R.B. Honzatko, and G.K. Amarasinghe Structure of the Ebola VP35 interferon inhibitory domain Proc. Natl. Acad. Sci. USA 106 2009 411 416
26. D.W. Leung, K.C. Prins, D.M. Borek, M. Farahbakhsh, J.M. Tufariello, P. Ramanan, J.C. Nix, L.A. Helgeson, Z. Otwinowski, and R.B. Honzatko Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 Nat. Struct. Mol. Biol. 17 2010 165 172
27. L.W. Leung, M.S. Park, O. Martinez, C. Valmas, C.B. López, and C.F. Basler Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells Immunol. Cell Biol. 89 2011 792 802
28. D.W. Leung, C.F. Basler, and G.K. Amarasinghe Molecular mechanisms of viral inhibitors of RIG-I-like receptors Trends Microbiol. 20 2012 139 146
29. S. Li, G.A. Peters, K. Ding, X. Zhang, J. Qin, and G.C. Sen Molecular basis for PKR activation by PACT or dsRNA Proc. Natl. Acad. Sci. USA 103 2006 10005 10010
30. E. Mühlberger, B. Lötfering, H.D. Klenk, and S. Becker Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes J. Virol. 72 1998 8756 8764
31. E. Mühlberger, M. Weik, V.E. Volchkov, H.D. Klenk, and S. Becker Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems J. Virol. 73 1999 2333 2342
32. R.C. Patel, and G.C. Sen PACT, a protein activator of the interferon-induced protein kinase, PKR EMBO J. 17 1998 4379 4390
33. C.V. Patel, I. Handy, T. Goldsmith, and R.C. Patel PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR J. Biol. Chem. 275 2000 37993 37998
34. G.A. Peters, R. Hartmann, J. Qin, and G.C. Sen Modular structure of PACT: distinct domains for binding and activating PKR Mol. Cell. Biol. 21 2001 1908 1920
35. G.A. Peters, S. Li, and G.C. Sen Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis J. Biol. Chem. 281 2006 35129 35136
36. K.C. Prins, W.B. Cárdenas, and C.F. Basler Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 J. Virol. 83 2009 3069 3077
37. K.C. Prins, J.M. Binning, R.S. Shabman, D.W. Leung, G.K. Amarasinghe, and C.F. Basler Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function J. Virol. 84 2010 10581 10591
38. K.C. Prins, S. Delpeut, D.W. Leung, O. Reynard, V.A. Volchkova, S.P. Reid, P. Ramanan, W.B. Cárdenas, G.K. Amarasinghe, V.E. Volchkov, and C.F. Basler Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs J. Virol. 84 2010 3004 3015
39. P. Ramanan, M.R. Edwards, R.S. Shabman, D.W. Leung, A.C. Endlich-Frazier, D.M. Borek, Z. Otwinowski, G. Liu, J. Huh, C.F. Basler, and G.K. Amarasinghe Structural basis for Marburg virus VP35-mediated immune evasion mechanisms Proc. Natl. Acad. Sci. USA 109 2012 20661 20666
40. J.W. Schoggins, and C.M. Rice Interferon-stimulated genes and their antiviral effector functions Curr. Opin. Virol. 1 2011 519 525
41. M. Schümann, T. Gantke, and E. Mühlberger Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain J. Virol. 83 2009 8993 8997
42. R.S. Shabman, D.W. Leung, J. Johnson, N. Glennon, E.E. Gulcicek, K.L. Stone, L. Leung, L. Hensley, G.K. Amarasinghe, and C.F. Basler DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function J. Infect. Dis. 204 Suppl 3 2011 S911 S918
43. M. Singh, D. Castillo, C.V. Patel, and R.C. Patel Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation Biochemistry 50 2011 4550 4560
44. C.F. Spiropoulou, P. Ranjan, M.B. Pearce, T.K. Sealy, C.G. Albariño, S. Gangappa, T. Fujita, P.E. Rollin, S.T. Nichol, T.G. Ksiazek, and S. Sambhara RIG-I activation inhibits ebolavirus replication Virology 392 2009 11 15
45. S. Theriault, A. Groseth, G. Neumann, Y. Kawaoka, and H. Feldmann Rescue of Ebola virus from cDNA using heterologous support proteins Virus Res. 106 2004 43 50
46. M. Trunschke, D. Conrad, S. Enterlein, J. Olejnik, K. Brauburger, and E. Mühlberger The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals Virology 441 2013 135 145
47. Y. Zhu, N.C. Cherukuri, J.N. Jackel, Z. Wu, M. Crary, K.J. Buckley, D.M. Bisaro, and D.S. Parris Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells J. Virol. 86 2012 3038 3049